Organization (Academic)
Kansas State University
ClinicalTrials.gov lists Kansas State University as lead sponsor of 31 trials. It has 1 active development program.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Kansas State University., via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Kansas State University: 31 lead-sponsored trials and 1 legal-entity registration.
Disease areas (33)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Obesity | 8 |
| Diabetes Mellitus | 7 |
| Hyperglycemia | 5 |
| Anemia | 3 |
| Anemia, Iron-Deficiency | 3 |
Showing 5 of 33 disease areas.
Trials by start year as sponsor or collaborator (18)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 4 |
| 2024 | 1 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 3 |
| 2019 | 4 |
| 2018 | 2 |
| 2017 | 3 |
| 2016 | 6 |
Showing 10 of 18 years.
Prediction, not a registry value: median of 22 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 8 months across 22 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (1)
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Transcranial Magnetic Stimulation | Stuttering | Not reported | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0% hit target (n=5) | 40% on time (n=5) |
Journals published in (62)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| BMC public health | 3 |
| Current developments in nutrition | 3 |
| Journal of fluency disorders | 3 |
| Journal of physical activity & health | 3 |
| Military medicine | 3 |
Showing 5 of 62 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 1 | 0 | 1993-05-18 |
Financing and grant events (183)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-19 | NIH grant | 200,000 | Reporter |
| 2025-09-19 | NIH grant | 913,625 | Reporter |
| 2025-09-03 | NIH grant | 200,000 | Reporter |
| 2025-08-26 | NIH grant | 2,250,623 | Reporter |
| 2025-08-26 | NIH grant | 282,674 | Reporter |
Showing 5 of 183 events.
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 2 |
Manufacturing and distribution sites (1)
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| Kansas State University | Manhattan, US | FDA |
Organization relationships (4)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| United States Department of Agriculture Foreign Agricultural Service | Co sponsors trial with | 3 |
| National Institute for Medical Research, Tanzania | Co sponsors trial with | 1 |
| Project Concern International - Tanzania | Co sponsors trial with | 1 |
| American Academy of Nurse Practitioners | Co sponsors trial with | 1 |
Latest dated events (229)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-19 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-09-19 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-09-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 229 events.
Biomarkers this organization publishes on (167)
Shown in this order: most publications first.
Showing 5 of 167 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda recalls, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.